Diagnosis and therapy of chronic systemic co-infections in Lyme disease and other tick-borne infectious diseases

Townsend Letter for Doctors and Patients, April, 2007 by Garth L. Nicolson

Lipid Replacement Therapy for Chronic Infections and Restoring Mitochondrial Function

Lipid Replacement Therapy is useful in providing membrane lipids in unoxidized forms to repair nerve and mitochondrial membranes that are damaged by heavy metals, chemicals, and infections. (20) For LD patients, we recommend the oral supplement Healthy Aging containing NTFactor (Nutritional Therapeutics). This product comes as tablets that are taken twice per day. For children, it should be ground up between two spoons into a coarse powder that can be added to several spoonfuls of applesauce. The NTFactor is not bitter, but it is slightly sour, and some children actually like the taste. The dose should be four to six tablets twice per day for adults. For children: one-half to one tablet for children up to two years-old; two tablets for children two to three years old; three to four tablets for children four to five years old; and four to five tablets for children five years old and older. Research has demonstrated no adverse responses with NTFactor, even at many times these doses. Since this formulation is a completely natural membrane lipid mixture, there are no known toxicities and no known toxic dose limits. NTFactor can also be taken in a form with vitamins, minerals, and probiotics (Propax). Lipid Replacement Therapy has been shown to improve fatigue scores and mitochondrial function in various chronic illnesses. (20)

Prof. Garth L. Nicolson

Department of Molecular Pathology

The Institute for Molecular Medicine

16371 Gothard St.

Huntington Beach, California 92647

714-596-6636, Fax: 714-596-3791

gnicolson@immed.org

www.immed.org.

*The author has no financial interest in any products discussed in this contribution.

Notes

1. Burgdorfer WA, Barbour AG, Hayes SF, et al. Lyme disease--a tick-borne spirochetosis? Science. 1982; 216:1317-1319.

2. Kind A, Schned E, Anderson F, et al. Lyme disease guidelines for Minnesota clinicians: Epidemiology, microbiology, diagnosis, treatment and prevention. Minnesota Department of Public Health, 1999. Available at: http://www.state.mn.us/divs/dpc/adps/lyme/guideline.> 3. Gale A, Ringdahl E. Tick-borne diseases. Amer Fam Physican. 2001; 64:461-466. Available at: http://www.aafp.org/afp/200110801/461.> 4. Burrascano JJ, Jr. Advanced topics in Lyme disease. Diagnostic hints and treatment guidelines for Lyme and other tick borne illnesses. LymeNet On-Line Library, Burrascano Treatment Guidelines, 2000. Available at: http://www2.lymenet.org/domino/file.nsf/UID/guidelines.> 5. Nicolson GL, Nasralla M, Franco AR, et al. Diagnosis and integrative treatment of intracellular bacterial infections in chronic fatigue and fibromyalgia syndromes, Gulf War illness, rheumatoid arthritis and other chronic illnesses. Clin Pract Alt Med. 2000; 1(2):92-102. Available at: http://www.immed.org/illness/infectious_disease_research.> 6. Nicolson GL, Nasralla M, Franco AR, et al. Mycoplasmal infections in fatigue illnesses: Chronic fatigue and fibromyalgia syndromes, Gulf War illness and rheumatoid arthritis. J Chronic Fatigue Syndr. 2000; 6(3):23-39. Available at: http://www.immed.org/illness/infectious_disease_research.>